期刊文献+

人表皮生长因子受体2靶向新型高分子超声造影剂的制备及体外寻靶实验研究 被引量:5

Reparation of human epithelial growth factor receptor 2-targeted polymer ultrasound contrast agents with liquid perfluorocarbons and in vitro experiment
原文传递
导出
摘要 目的制备一种新型血管外靶向超声造影剂——包裹液态氟碳的人表皮生长因子受体2(HER2)靶向高分子纳米球,并观察其体外寻靶、显影能力。方法首先采用单乳化法制备包裹液态氟碳的高分子PLGA纳米球(PFH—PLGA),然后通过碳二亚胺法将靶向HER2的特异性抗体trastuzumab连接到纳米球表面,制成靶向纳米球(PFH—PLGA—tra);检测其一般表征;免疫荧光法检测trastuzumab与纳米球连接情况;体外寻靶实验观察PFH—PLGA-tra与人乳腺癌细胞MCF-7的结合情况;体外加热法观察液态氟碳相变情况;体外观察纳米球增强超声显影效果。结果靶向液态氟碳造影剂平均粒径为(261±28)nm;免疫荧光法显示trastuzumab被成功地连接到了纳米球上;体外寻靶实验示,该靶向造影剂较多并牢固地聚集在表达HER2的MCF-7细胞表面,对照组未见造影剂和MCF-7的结合;体外热相变实验示,较多纳米球转变为微泡;体外显影实验示,造影剂回声强度和灰度均较双蒸水明显增强(P〈0.05)。结论通过单乳化法和碳二亚胺法成功制备了靶向HER2的液态氟碳高分子超声造影剂,其粒径较小,靶向能力较强,具有相变潜能,有望成为HER2阳性肿瘤血管外显影、治疗的理想造影剂。 Objective To prepare a novel extravascular human epithelial growth factor receptor 2 (HER2)-targeted polylactic-co-glycolie acid (PLGA)-COOH ultrasound contrast agent with liquid perfluorocarbons(PFH-PLGA-tra), and to observe it's general properties and itrs effects on ultrasound imaging in vitro. Methods Polymeric nanocapsules of liquid perfluorocarbons were prepared by the single emulsion technique and conjugated with trastuzumab monoclonal antibody by EDC/NHS. The general characteristics were observed. The conjugation was demonstrated by immunofluorescence and the targeting performance of the agent was checked in human MCF-7 cells line in vitro. The encapsulation of liquid fluorocarbons was detected by heating in vitro. The effects on ultrasound imaging were observed in vitro. Results The mean diameter of agents was (261 + 28) nm. The targeted nanocapsules were positive in immunofluorescence. In the targeted study,it was shown that a number of targeted nanocapsules conjugated with MCF-7 cells in vitro. Droplet-to-bubble transition experiment in vitro showed that there were no nano/ microbubbles formed by heating in control groups at 80~C, while there were a lot of nano/microbubbles appeared in nanocapsules formulations at 80 ~C. The agents presented a good ultrasound imaging in vitro. Conchusions The HER2-targeted polymeric nanocapsules of liquid perfluorocarbons are successfully prepared,which may become a novel extravascular targeted ultrasound contrast agents.
出处 《中华超声影像学杂志》 CSCD 北大核心 2014年第1期66-70,共5页 Chinese Journal of Ultrasonography
基金 国家自然科学基金(81227801,81130025,81110219,81371579) 重庆市高校创新团队计划(KJTD201303)
关键词 超声检查 微气泡 纳米技术 液态氟碳 Ultrasonography~ Mierobubbles~ Nanotechnology Liquid perfluorocarbons
  • 相关文献

参考文献16

  • 1Deshpande N,Needles A,Willmann JK.Molecular ultrasoundimagings current status and future directions[J].Clin Radiol,2010,65:567-581.
  • 2王志刚.超声造影剂基础研究现状与进展[J].中华医学超声杂志(电子版),2011,8(5):924-928. 被引量:32
  • 3Martin KH,Dayton PA.Current status and prospects formicrobubbles in ultrasound theranostics[J].Wiley InterdiscipRev Nanomed Nanobiotechnol,2013?5:329-345.
  • 4郑海荣,严飞,邓志婷.超声探针是超声分子成像技术的关键[J].中华核医学与分子影像杂志,2013,33(1):1-3. 被引量:3
  • 5Pysz MA?Gambhir SS? Willmann JK.Molecular imaging:currentstatus and emerging strategies.Clin Radiol,2010,65:500-516.
  • 6Behm CZ,Lindner JR.Cellular and molecular imaging withtargeted contrast ultrasound[J].Ultrasound Q,2006,22:67-72.
  • 7韦馨,唐红.靶向超声造影剂在制备领域中的研究进展[J].临床超声医学杂志,2012,14(12):833-836. 被引量:7
  • 8申宝忠.走近分子影像学:发展的回顾与展望[J].中华放射学杂志,2013,47:40-44.
  • 9Bagossi P,Horvath G,Vereb G,et al.Molecular modeling ofnearly full-length ErbB2 receptor[J],Biophys J,2005,88; 1354-1363.
  • 10Marmor MD,Skaria KB,Yarden Y.Signal transduction andoncogenesis by ErbB/HER receptors[J].Int J Radiat Oncol BiolPhys,2004,58:903-913.

二级参考文献43

  • 1赵应征,鲁翠涛,张彦,许景峰,王辰允,罗渝昆,唐杰,梅兴国.环境因素对脂质造影剂的稳定性和回声效率的影响[J].中华医学超声杂志(电子版),2007,4(5):315-317. 被引量:2
  • 2张群霞,王志刚,冉海涛,彭晓琼,李晓东,彭明利,刘宪华,景香香,杨春江.超声微泡促进肿瘤细胞报告基因转染[J].临床超声医学杂志,2005,7(2):78-80. 被引量:17
  • 3刘娅妮,邓又斌,项光亚,刘冰冰,张奇,龙娜.抗体偶联白蛋白声学微气泡的方法学研究[J].中国超声医学杂志,2006,22(5):321-323. 被引量:7
  • 4Sirsi S, Borden M. Microbubble compositions, properties and biomedical applications. Bubble Sci Eng Technol, 2009,1 (1-2) : 3-17.
  • 5Qu H, Jiao KF. Interactions between protein and sugar. Foreign Med Sci Sect Pharm, 1999,26 (2) : 95-98.
  • 6ter Haar GR. Uhrasonic contrast agents: safety considerations reviewed. Eur J Radiol, 2002,41 ( 3 ) : 217-221.
  • 7Hernot S, Klibanov AL. Microbubbles in ultrasound-triggered drug and gene delivery. Adv Drug Deliv Rev, 2008,60(10) : 1153-1166.
  • 8Straub JA, Chickering DE, Church CC, et al. Porous PLGA microparticles: A1-700, an intravenously administered ultrasound contrast agent for use in echocardiography. J Control Release,2005, 108( 1 ) :21-52.
  • 9Kaufmann BA, Sanders JM, Davis C, et al. Molecular imaging of inflammation in atherosclerosis with targeted ultrasound detection of vascular cell adhesion molecule- 1.Circulation, 2007,116(3 ) : 276-284.
  • 10Kaufmann BA, Lewis C, Xie A, et al. Detection of recent myocardial ischaemia by molecular imaging of P-selection with targeted contrast echocardiography. Eur Heart J, 2007,28 (16) : 2011-2017.

共引文献40

同被引文献43

  • 1Pignatelli M, Cardillo MR, Hanby A, et al.Integrins and their accessory adhesion molecules in mammary carcinomas: loss of polarization in poorly differentiated tumors [J]. Hum Pathol, 1992,23: 1159-1166.
  • 2Price DJ0 Miralem T, Jiang S, et al. Role of vascular endothelial growth factor in the stimulation of cellular invasion and signaling of breast cancer ceUs[J].Cell Growth Differ,2001,12:129-135.
  • 3Subik K,Lee JF,Baxter L,et al.The Expression patterns of ER, PR, HER2, CK5/6, EGFR, Ki-67 and AR by immunohistoehemical analysis in breast cancer cell lines[J]. Breast Cancer (Auckl) ,2010,4:35-41.
  • 4Milgroom A, Intrator M, Madhavan K, et al. Mesoporous silica nanopartieles as a breast-cancer targeting ultrasound contrast agent[J]. Colloids Surf B Biointerfaces, 2013,10: 1-6.
  • 5Warram JM, Sorace A, Saini R, et al.A triple-targeted ultrasound contrast agent provides improved localization to tumor vasculature[J].J Ultrasound Med, 2011,30 : 921-931.
  • 6Pillai R, Marinelli ER, Fan H, et al. A phospholipid-PEG2000 conjugate of a vascular endothelial growth factor receptor 2 (VEGFR2)-targeting heterodimer peptide for eontrast-enhanced ultrasound imaging of angiogenesis [J]. Bioconjug Chem, 2010, 21:556-562.
  • 7Pochon S, Tardy I, Bussat P, et al. BR55: a lipopeptide-based VEGFR2-targeted ultrasound contrast agent for molecular imaging of angiogenesis[J].Invest Radiol, 2010,45: 89-95.
  • 8Bzyl J, Lederle W, Rix A, et al. Molecular and functional ultrasound imaging in differently aggressive breast cancer xenografts using two novel ultrasound contrast agents (BR55 and BR38) [J].Eur Radiol,2011,21:1988-1995.
  • 9Balazs Daniel A,Godbey WT.Liposomes for use in gene delivery[J].J Drug Deliv,2010,2011: 1-12.
  • 10Cochran MC, Eisenbrey J, Ouma RO, et al. Doxorubicin and paclitaxel loaded microbubbles for ultrasound triggered drug delivery[J].Int J Pharm,2011,414:161-170.

引证文献5

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部